AUTL
Autolus Therapeutics
AUTL
AUTL
71 hedge funds and large institutions have $204M invested in Autolus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
10.39% more ownership
Funds ownership: 54.3% → 64.69% (+10%)
8% more funds holding
Funds holding: 66 → 71 (+5)
Holders
71
Holding in Top 10
2
Calls
$334K
Puts
$3K
Top Buyers
| 1 | +$37.9M | |
| 2 | +$35.4M | |
| 3 | +$25.9M | |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$13.3M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$6.49M |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$961K | |
| 3 | -$916K | |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$214K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$202K |